SARS-CoV-2, Virology and Pathogenicity and phytomedicinal immunomodulators to curb covid-19 pandemic

被引:0
|
作者
Kumar, Sanjeev [1 ]
机构
[1] Univ Petr & Energy Studies, Dept Chem, Appl Sci Cluster, Dehra Dun, India
关键词
Covid-19; SARS Virus; Virology; plants; phytochemical; GINGER ZINGIBER-OFFICINALE; MOLECULAR DOCKING; MEDICINAL-PLANTS; VARIETIES; SARS-COV; CORONAVIRUS; VIRUS; INHIBITION; EXTRACT; IDENTIFICATION;
D O I
10.47750/pnr.2022.13.S06.115
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The new coronavirus, COVID-19 has sent the world into a medical and economic crisis and if not contained can cause unprecedented damage to the human population.COVID-19 is a new pathogen and a new coronavirus that poses a global threat to healthcare system worldwide and has already devoured many lives in different parts of the world. Till date, there is no specific vaccine or effective antiviral therapy against COVID-19 disease. The only way to prevent oneself is to maintain social distancing, maintain proper hygiene and simultaneously enhance the individual's immune response by incorporating immune boosters in daily diet, as health supplements and prophylaxis. Phytotherapy (herbalism) means usage of plants or herbs as medication to treat or prevent diseases and has a lot of potential. This phytomedicinal therapeutic approach proves to be cheaper and safer alternative and reduce the incidence of drug resistance and may modulate the immune system in preventing viral diseases. This traditional therapy has less side effects and bestow a general good health. It may suppress viral replication and reduce the clinical signs of viral diseases and can be promoted as immunomodulator. COVID 19 has been shown to engage the host cell ACE2 through its spike protein receptor binding domain (RBD) and natural phytochemical from plants have distinct effects on viral RBD and host ACE2 receptor complex. The present paper aims to present a comprehensive study of certain medicinal herbs to increase the immune potential and a promising option in the fore-front in healing COVID-19 ailments, concurrent with ICMR prescribed allopathic treatments.
引用
收藏
页码:844 / 859
页数:16
相关论文
共 50 条
  • [31] SARS-CoV-2 and COVID-19 for the ophthalmologist
    Brandao-de-Resende, Camilo
    Diniz-Filho, Alberto
    de Almeida Brito, Fabiano
    Vasconcelos-Santos, Daniel Vitor
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 49 (01): : 70 - 80
  • [32] SARS-CoV-2, COVID-19 and Neurodegeneration
    Toenges, Lars
    Klebe, Stephan
    [J]. BRAIN SCIENCES, 2022, 12 (07)
  • [33] Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic
    Mathew, Hannah R.
    Choi, May Y.
    Parkins, Michael D.
    Fritzler, Marvin J.
    [J]. BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [34] A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time
    Al-Awwal, Nasruddeen
    Dweik, Ferris
    Mahdi, Samira
    El-Dweik, Majed
    Anderson, Stephen H.
    [J]. PATHOGENS, 2022, 11 (03):
  • [35] SARS-Cov-2 in peritoneal fluid: an important finding in the Covid-19 pandemic
    Barberis, A.
    Rutigliani, M.
    Belli, F.
    Ciferri, E.
    Mori, M.
    Filauro, M.
    [J]. BRITISH JOURNAL OF SURGERY, 2020, 107 (10) : E376 - E376
  • [36] COVID-19 pandemic crisis-a complete outline of SARS-CoV-2
    Shaikh, Sana Saffiruddin
    Jose, Anooja P.
    Nerkar, Disha Anil
    Vijaykumar KV, Midhuna
    Shaikh, Saquib Khaleel
    [J]. FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 6 (01)
  • [37] To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic
    Parperis, Konstantinos
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (01)
  • [38] Lessons Learned during the Coronavirus – Covid-19 (SARS-CoV-2) Pandemic
    Bruzzese, Stacey L.
    [J]. Journal of Validation Technology, 2020, 26 (02)
  • [39] Two years of SARS-CoV-2 pandemic and COVID-19 in Lombardy, Italy
    Mannucci, Pier Mannuccio
    Galbussera, Alessia Antonella
    D'Avanzo, Barbara
    Tettamanti, Mauro
    Remuzzi, Giuseppe
    Fortino, Ida
    Leoni, Olivia
    Harari, Sergio
    Nobili, Alessandro
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2023, 18 (05) : 1445 - 1451
  • [40] Otolaryngology Residency Application during the SARS-CoV-2 (COVID-19) Pandemic
    Quesada, Pompeyo R.
    Solis, Roberto N.
    Diaz, Rodney C.
    Kraft, Shannon M.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2020, 163 (01) : 89 - 90